240 related articles for article (PubMed ID: 24467605)
1. The potential role of angiogenic factors in rheumatoid arthritis.
Azizi G; Boghozian R; Mirshafiey A
Int J Rheum Dis; 2014 May; 17(4):369-83. PubMed ID: 24467605
[TBL] [Abstract][Full Text] [Related]
2. Targeting rheumatoid tenosynovial angiogenesis with cytokine inhibitors.
Jain A; Kiriakidis S; Brennan F; Sandison A; Paleolog E; Nanchahal J
Clin Orthop Relat Res; 2006 May; 446():268-77. PubMed ID: 16456308
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of angiogenesis: ready for prime time?
Maracle CX; Tas SW
Best Pract Res Clin Rheumatol; 2014 Aug; 28(4):637-49. PubMed ID: 25481555
[TBL] [Abstract][Full Text] [Related]
4. Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.
Plum SM; Park EJ; Strawn SJ; Moore EG; Sidor CF; Fogler WE
BMC Musculoskelet Disord; 2009 May; 10():46. PubMed ID: 19409094
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and vasculogenesis in rheumatoid arthritis.
Szekanecz Z; Besenyei T; Szentpétery A; Koch AE
Curr Opin Rheumatol; 2010 May; 22(3):299-306. PubMed ID: 20305562
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis as a target in rheumatoid arthritis.
Koch AE
Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii60-7. PubMed ID: 14532152
[No Abstract] [Full Text] [Related]
8. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications.
Westra J; Molema G; Kallenberg CG
Curr Med Chem; 2010; 17(3):254-63. PubMed ID: 20214567
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience.
Thairu N; Kiriakidis S; Dawson P; Paleolog E
Angiogenesis; 2011 Sep; 14(3):223-34. PubMed ID: 21431303
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance.
Szekanecz Z; Szegedi G; Koch AE
J Investig Med; 1998 Feb; 46(2):27-41. PubMed ID: 9549225
[TBL] [Abstract][Full Text] [Related]
12. Tripterygium wilfordii Inhibiting Angiogenesis for Rheumatoid Arthritis Treatment.
Zhang W; Li F; Gao W
J Natl Med Assoc; 2017 Summer; 109(2):142-148. PubMed ID: 28599756
[TBL] [Abstract][Full Text] [Related]
13. CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1α-mediated pathway in rheumatoid arthritis.
Wang CH; Yao H; Chen LN; Jia JF; Wang L; Dai JY; Zheng ZH; Chen ZN; Zhu P
Arthritis Rheum; 2012 Jun; 64(6):1818-27. PubMed ID: 22170561
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in rheumatoid arthritis.
Maruotti N; Cantatore FP; Crivellato E; Vacca A; Ribatti D
Histol Histopathol; 2006 May; 21(5):557-66. PubMed ID: 16493585
[TBL] [Abstract][Full Text] [Related]
15. New insights in synovial angiogenesis.
Szekanecz Z; Besenyei T; Paragh G; Koch AE
Joint Bone Spine; 2010 Jan; 77(1):13-9. PubMed ID: 20022538
[TBL] [Abstract][Full Text] [Related]
16. The vasculature in rheumatoid arthritis: cause or consequence?
Paleolog EM
Int J Exp Pathol; 2009 Jun; 90(3):249-61. PubMed ID: 19563609
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in rheumatoid arthritis.
Szekanecz Z; Besenyei T; Paragh G; Koch AE
Autoimmunity; 2009 Nov; 42(7):563-73. PubMed ID: 19863375
[TBL] [Abstract][Full Text] [Related]
18. From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis.
Harry LE; Paleolog EM
Birth Defects Res C Embryo Today; 2003 Nov; 69(4):363-74. PubMed ID: 14745976
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.
Veale DJ; Fearon U
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):941-7. PubMed ID: 16980216
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine in rheumatoid arthritis: a review to date.
Murphy G; Caplice N; Molloy M
Rheumatology (Oxford); 2008 Oct; 47(10):1446-51. PubMed ID: 18495821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
